Skip to content
Open Data Finder
Open Government Canada

Guidance Document for Industry - Review of Drug Brand Names

Published by Health Canada | Santé Canada

About this dataset

To provide market authorization holders direction on the process to be followed and information to be submitted to Health Canada regarding the potential for a proposed name to be misleading or confused with another product authorized for use in Canada with the aim of preventing medication errors.

Guidance Document for Industry - Review of Drug Brand Names · Open Data Finder